Harry J Leonhardt is GC & Chief Compliance Officer of Poseida Therapeutics, Inc.. Currently has a direct ownership of 214,640 shares of PSTX, which is worth approximately $2.03 Million. The most recent transaction as insider was on Mar 01, 2024, when has been sold 16,306 shares (Common Stock) at a price of $4.13 per share, resulting in proceeds of $67,343. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 215K
0% 3M change
48.85% 12M change
Total Value Held $2.03 Million

HARRY J LEONHARDT Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 01 2024
SELL
Payment of exercise price or tax liability
$67,343 $4.13 p/Share
16,306 Reduced 7.06%
214,640 Common Stock
Mar 01 2024
BUY
Grant, award, or other acquisition
-
80,743 Added 25.9%
230,946 Common Stock
Mar 01 2023
SELL
Payment of exercise price or tax liability
$23,128 $5.35 p/Share
4,323 Reduced 2.91%
144,203 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
-
92,772 Added 38.45%
148,526 Common Stock
Mar 01 2022
BUY
Grant, award, or other acquisition
-
50,000 Added 50.0%
50,000 Common Stock
HJL

Harry J Leonhardt

GC & Chief Compliance Officer
San Diego, CA

Track Institutional and Insider Activities on PSTX

Follow Poseida Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PSTX shares.

Notify only if

Insider Trading

Get notified when an Poseida Therapeutics, Inc. insider buys or sells PSTX shares.

Notify only if

News

Receive news related to Poseida Therapeutics, Inc.

Track Activities on PSTX